These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 934519

  • 21. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
    Ehrly AM.
    Med Welt; 1975 Mar 07; 26(10):446-55. PubMed ID: 1123988
    [No Abstract] [Full Text] [Related]

  • 22. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion.
    Ohashi S, Iwatani M, Hyakuna Y, Morioka Y.
    Arzneimittelforschung; 1985 Mar 07; 35(7A):1203-8. PubMed ID: 4074436
    [Abstract] [Full Text] [Related]

  • 23. [Clinical trials of a vasoactive drug in arteriopathies of the limbs].
    Courbier R, Jausseran JM, Reggi M.
    Sem Hop Ther; 1977 Jan 23; 53(1):47-51. PubMed ID: 854750
    [No Abstract] [Full Text] [Related]

  • 24. [Changes in the muscle flow (determinated with 133 xenon) in the lower limbs after intra-arterial injection of acetylcholine in normal subjects and in patients with arterial diseases].
    Nuzzaci G, Fantini F, Viola S, Pesciullesi E, Boccuni M.
    Minerva Cardioangiol; 1973 Jan 23; 21(7):503-12. PubMed ID: 4756345
    [No Abstract] [Full Text] [Related]

  • 25. [Thermometry of the skin of the lower extremities in obliterative arterial diseases].
    Varava BN, Ozerova OE, Molchanova LD.
    Sov Med; 1982 Jan 23; (2):103-6. PubMed ID: 7063958
    [No Abstract] [Full Text] [Related]

  • 26. Effect of nicotinic acid and dipyridamole on tissue blood flow in peripheral vascular disease.
    Smith RS, Warren DJ.
    Pharmatherapeutica; 1981 Jan 23; 2(9):597-600. PubMed ID: 7267676
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG, Nelson SR, Hampton KK, Casali B, Boothby M, Prentice CR.
    Blood Coagul Fibrinolysis; 1990 Oct 23; 1(4-5):385-8. PubMed ID: 2133215
    [Abstract] [Full Text] [Related]

  • 28. [Action of nitrates on pressure and volume in the peripheral circulation of patients with coronary heart disease and with peripheral arterial occlusive diseases].
    Caesar K, Niemeyer H, Hossmann V, Saborowski F.
    Verh Dtsch Ges Inn Med; 1990 Oct 23; 83():1738-41. PubMed ID: 347799
    [No Abstract] [Full Text] [Related]

  • 29. [Diagnosis of obliterating diseases of the vessels of the lower extremities using an ultrasonic method].
    Alent'ev AA, Prokhorov GG, Sukhov VK, Esipovich ID.
    Vestn Khir Im I I Grek; 1986 Oct 23; 137(10):48-50. PubMed ID: 2948316
    [Abstract] [Full Text] [Related]

  • 30. [Effect of piribedil on circulatory volume in muscles of the extremities and in the brain].
    Klemm J.
    Minerva Med; 1976 May 26; 67(26):1712-3. PubMed ID: 934524
    [No Abstract] [Full Text] [Related]

  • 31. The effect of induced arterial hypertension upon regional blood flow in subcutaneous tissue in patients with arterial insufficiency of the legs.
    Henriksen O, Wisborg K.
    Scand J Clin Lab Invest; 1975 Mar 26; 35(2):115-20. PubMed ID: 1145106
    [Abstract] [Full Text] [Related]

  • 32. Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.
    Rondot P, Bathien N, Dumas JL.
    Adv Neurol; 1975 Mar 26; 9():373-81. PubMed ID: 1096574
    [No Abstract] [Full Text] [Related]

  • 33. [Use of raubasine in long-term therapy of obliterating arteriopathies].
    Andreozzi GM, Signorelli S, Magnano V, Savoca N, Mazzerbo A, Cottini E, Sorrentino F.
    Minerva Cardioangiol; 1979 Mar 26; 27(1-2):61-6. PubMed ID: 471237
    [No Abstract] [Full Text] [Related]

  • 34. [Use of isotopes for the determination of blood-flow volume in the leg during arterial occlusive diseases of the lower limbs].
    Kollath J, Krause E, Manegold KH, Spitz PA.
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Mar 26; 0(0):suppl:369-70. PubMed ID: 4366709
    [No Abstract] [Full Text] [Related]

  • 35. Thermographic patterns of lower limb arterial disease.
    Lovisatti L, Mora L, Pistolesi GF.
    Bibl Radiol; 1975 Mar 26; (6):107-114. PubMed ID: 1180841
    [Abstract] [Full Text] [Related]

  • 36. Action of piribedil in Parkinson's disease: I.V. test and oral treatment.
    Emile J, Chanelet J, Truelle JL, Bastard J.
    Adv Neurol; 1975 Mar 26; 9():409-13. PubMed ID: 1096577
    [No Abstract] [Full Text] [Related]

  • 37. [Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
    Guagliano G, Bagliani A, Borri P.
    Minerva Med; 1976 May 19; 67(25):1648-55. PubMed ID: 778666
    [No Abstract] [Full Text] [Related]

  • 38. [Status of lymphatic vessels, lymph flow and lymph toxicity in patients with obliterating arterial diseases of the lower extremities].
    Kungurtsev VV, Shimanko AI, Dibirov MD, Pishchita AN, Esina MP.
    Khirurgiia (Mosk); 1990 May 19; (5):47-50. PubMed ID: 2391937
    [Abstract] [Full Text] [Related]

  • 39. Blood flow properties and walking performance in chronic arterial occlusive disease.
    Angelkort B, Spürk P, Habbaba A, Mähder M.
    Angiology; 1985 May 19; 36(5):285-92. PubMed ID: 3896044
    [Abstract] [Full Text] [Related]

  • 40. [MR-Imaging of lower leg muscle perfusion].
    Leppek R, Hoos O, Sattler A, Kohle S, Azzam S, Al Haffar I, Keil B, Ricken P, Klose KJ, Alfke H.
    Herz; 2004 Feb 19; 29(1):32-46. PubMed ID: 14968340
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.